LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1209 | 1035 | 4093 | 0.2528 | -0.0848 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1209 | 1062 | 4121 | 0.2577 | -0.0709 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1209 | 962 | 3980 | 0.2417 | -0.1248 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1209 | 966 | 4252 | 0.2272 | -0.1166 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1209 | 1161 | 4376 | 0.2653 | -0.0218 |
| MCF7 | GSK1059615 | 10 | uM | LJP6 | 1 | C01 | 72 | hr | 1209 | 642 | 3823 | 0.1679 | -0.3172 |
| MCF7 | GSK1059615 | 10 | uM | LJP6 | 2 | C01 | 72 | hr | 1209 | 799 | 4093 | 0.1952 | -0.2100 |
| MCF7 | GSK1059615 | 10 | uM | LJP6 | 3 | C01 | 72 | hr | 1209 | 940 | 4121 | 0.2281 | -0.1329 |
| MCF7 | GSK1059615 | 10 | uM | LJP5 | 1 | E01 | 72 | hr | 1209 | 608 | 3980 | 0.1528 | -0.3299 |
| MCF7 | GSK1059615 | 10 | uM | LJP5 | 2 | E01 | 72 | hr | 1209 | 631 | 4252 | 0.1484 | -0.3014 |
| MCF7 | GSK1059615 | 10 | uM | LJP5 | 3 | E01 | 72 | hr | 1209 | 754 | 4376 | 0.1723 | -0.2249 |
| MCF7 | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 1209 | 4003 | 3980 | 1.0058 | 1.0067 |
| MCF7 | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 1209 | 4520 | 4252 | 1.0628 | 1.0683 |
| MCF7 | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 1209 | 3978 | 4376 | 0.9090 | 0.8998 |
| MCF7 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 1209 | 3504 | 3980 | 0.8804 | 0.8571 |
| MCF7 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 1209 | 4105 | 4252 | 0.9653 | 0.9614 |
| MCF7 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 1209 | 4067 | 4376 | 0.9294 | 0.9226 |
| MCF7 | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 1209 | 3778 | 3980 | 0.9492 | 0.9403 |
| MCF7 | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 1209 | 3995 | 4252 | 0.9394 | 0.9322 |
| MCF7 | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 1209 | 4056 | 4376 | 0.9268 | 0.9198 |
| MCF7 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1209 | 3528 | 3980 | 0.8864 | 0.8645 |
| MCF7 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1209 | 4220 | 4252 | 0.9923 | 0.9915 |
| MCF7 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 1209 | 4243 | 4376 | 0.9696 | 0.9670 |
| MCF7 | Brivanib | 3.33 | uM | LJP5 | 1 | P14 | 72 | hr | 1209 | 3841 | 3980 | 0.9651 | 0.9590 |
| MCF7 | Brivanib | 3.33 | uM | LJP5 | 2 | P14 | 72 | hr | 1209 | 4309 | 4252 | 1.0132 | 1.0145 |